79 results
Page 2 of 4
8-K
EX-99.1
0rpew
14 Aug 23
CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and Continued rapid pace of enrollment with ~75% of expected patients now enrolled
9:25am
8-K
EX-99.1
v5i0n02hpzd20
15 May 23
CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides
8:36am
424B4
vyc0nqzv1
2 Dec 22
Prospectus supplement with pricing info
5:40pm
8-K
EX-99.1
d974uuqy885ho5qdw8
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
9s8tz4eenp7zqhe6w497
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-99.1
vfcg09i tp
24 Oct 22
Other Events
5:15pm
8-K
EX-99.1
3milg2
15 Aug 22
CNS Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:09am
8-K
EX-99.1
s4d7kd j1rj13
16 May 22
CNS Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:38pm